Is Multiple Cavernoma a Developmental Defect in Schizophrenia?
Publication: American Journal of Psychiatry
To the Editor: The neurodevelopmental hypothesis of schizophrenia suggests that the interaction between genetic and environmental events during critical periods of neuronal growth in utero may adversely affect neuronal architecture in adulthood (1). Multiple cavernoma (multiple cavernous hemangioma) is a developmental defect of small blood vessels that causes diffuse honeycombing of vascular spaces in the brain (2). This results in sedimentation, thrombosis, and calcification, which can be seen on magnetic resonance imaging (MRI). Here we present a case of schizophrenia with obsessive-compulsive symptoms in a woman with familial bilaterally diffuse cavernoma.
Ms. A, an 18-year-old unmarried woman, was admitted to our ward with psychosis and obsessive-compulsive symptoms. She had ego-dystonic mental obsessions (she reported having “ugly thoughts” about others) and an ego-syntonic delusion that others could read these thoughts. She reported an extensive family history. Her mother had a meningioma, and her brother and uncle suffered from cavernous hemangioma (cavernoma). Her brother also suffered from epilepsy. There was no family history of schizophrenia or obsessive-compulsive disorder. During high school, she was socially withdrawn and preferred to stay at home. One year before her admission, she developed paranoid delusions about her classmates but was not treated.On admission, results of Ms. A’s neurological and dilated ophthalmoscopic examinations were normal. A computerized tomography scan showed two suspected enhancements. Subsequent MRI demonstrated multiple cerebral cavernomas bilaterally, with typical “rings” visible on T2 imaging. Cavernomas were most abundant in the temporal and frontal regions. Her EEG was normal. An exacerbation of her paranoid thoughts during the first hospital week did not respond to 5 weeks of risperidone treatment (maximum dose=6 mg/day). At that time, she was switched to olanzapine, 20 mg/day, with a remission of her psychosis within 3 weeks. The addition of sertraline, 50 mg/day, relieved her obsessive-compulsive symptoms after an additional 4 weeks.
Familial cavernoma is an autosomal dominant disorder with incomplete penetrance (3). The 7q locus might harbor the causative gene (4). Common clinical signs of multiple cavernoma include neurological deficits, seizures, and hemorrhage (2), although these were not present in this patient. It is possible that this patient’s schizophrenia was causally linked to the developmental effects of her hereditary diffuse brain vessel malformation. Alternatively, this could represent an incidental and extremely rare comorbidity. (We found no such cases in the literature.)
References
1.
Bloom FE: Advancing a neurodevelopmental origin for schizophrenia. Arch Gen Psychiatry 1993; 50:224–227
2.
Maraire J, Awad I: Intracranial cavernous malformation: lesion behavior and management strategies. Neurosurgery 1995; 37:591–605
3.
Labauge P, Laberge S, Brunereau L, Levy C, Tournier-Lasserve E (Societé Française de Neurochirurgie): Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families. Lancet 1998; 352:1892–1897
4.
Sarraf D, Payne AM, Kitchen ND, Sehmi KS, Downes SM, Bird AC: Familial cavernous hemangioma: an expanding ocular spectrum. Arch Ophthalmol 2000; 118:969–973
Information & Authors
Information
Published In
History
Published online: 1 May 2004
Published in print: May 2004
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).